Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual...

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Biochemistry

Background:

• Checkpoint kinase-1 (Chk-1 kinase) is a critical regulator of DNA damage response.
• Targeting Chk-1 kinase is a promising strategy for cancer therapy, particularly in combination with DNA-damaging agents.
• Identifying novel Chk-1 kinase inhibitors is essential for developing new anti-cancer drugs.

Purpose of the Study:

• To virtually screen a large compound library for potential Chk-1 kinase inhibitors.
• To identify novel chemical scaffolds with Chk-1 kinase inhibitory activity.
• To establish a knowledge-based strategy for efficient virtual screening of kinase inhibitors.

Main Methods:

• A knowledge-based virtual screening strategy was employed, starting with generic physical property filtering and removal of undesirable chemical functionalities.
• A 3D pharmacophore screen identified compounds with kinase binding motifs.
• Docking of approximately 200,000 compounds into the Chk-1 kinase active site using FlexX-Pharm, followed by postfiltering with a consensus scoring scheme and visual inspection.

Main Results:

• 103 compounds were selected for experimental testing.
• 36 of the tested compounds demonstrated dose-dependent inhibition of Chk-1 kinase.
• Inhibitory activity was observed across four distinct chemical classes, with IC50 values ranging from 110 nM to 68 µM.

Conclusions:

• The virtual screening strategy successfully identified novel Chk-1 kinase inhibitors.
• The identified compounds represent promising starting points for further drug development efforts targeting Chk-1 kinase.
• This study validates a robust computational approach for discovering kinase inhibitors.